Skip to content
Unrated Drug recall · FDA · Published March 13, 2026

Endo USA Buprenorphine Injection Recall: Crystallization Risk

Endo USA recalls 5x1mL Buprenorphine injections due to crystallization risk. Affected lots expire 02/2027 and 03/2027. Contact for return instructions.

🇺🇸 FDA recall #D-0527-2026DrugEndo USA ›
Take action

Contact the company

Recalling firmENDO USA, Inc.870 Parkdale Rd · Rochester, MI 48307-1740
✎ GovInfoNow plain-language explainer

Endo USA is recalling specific buprenorphine injection vials that may crystallize, potentially causing safety issues. This recall affects prescription-only medication with specific lot numbers and expiration dates. Read more at govinfonow.com/recall/31434-endo-usa-buprenorphine-injection-recall-crystallization-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/31434-endo-usa-buprenorphine-injection-recall-crystallization-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0527-2026

Cite this page

“Endo USA Buprenorphine Injection Recall: Crystallization Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31434-endo-usa-buprenorphine-injection-recall-crystallization-risk. Based on FDA recall #D-0527-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0527-2026%22&limit=1).

ENDO USA, Inc. voluntarily recalled Buprenorphine Hydrochloride Injection vials on March 13, 2026, due to crystallization identified as Buprenorphine free base, the FDA said. Owners should contact the company for a refund.

How to tell if you have it

  • Brand: Endo USA
  • Product: Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials
  • NDC: 42023-179-05
  • Lot codes: 84132 (Exp 02/28/2027), 87693 (Exp 03/31/2027)
  • Quantity: 34,293 vials

The hazard

The recall addresses crystallization in the injection solution, which has been identified as Buprenorphine free base. The FDA classified this Class II recall because use of the product could result in serious adverse health consequences or death.

Context

ENDO USA, Inc. has 4 other recalls on record since November 18, 2024. Other recent recalls of similar products include Par Health Buprenorphine Injection Recall (June 12, 2026), Par Health Recalls Buprenorphine Injections Due to Crystallization (September 8, 2026), and American Regent Epinephrine Injection Recall (August 11, 2026).

How to tell if you have this one

Check for vials labeled 'Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only' with lot numbers 84132 or 87693. The expiration dates are 02/28/2027 or 03/31/2027.

  • Brand
    Endo USA
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Details

    Look for lot numbers 84132 or 87693 on the vial label with expiration dates 02/28/2027 or 03/31/2027.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Mar 13, 202612. FDA classified it Class II: May 11, 202623. Published in FDA’s Enforcement Report: May 20, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Endo USA recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0527-2026 (March 13, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0527-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA